当前位置: X-MOL 学术N. Engl. J. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Improving the Outcome of Bad-Acting Hormone Receptor–Positive Breast Cancer
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2024-10-31 , DOI: 10.1056/nejme2411229
William J. GradisharFrom the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago.

The treatment approach for patients with estrogen receptor–positive, human epidermal growth factor receptor 2 (HER2)–negative metastatic breast cancer has changed dramatically over the past 20 year...

中文翻译:


改善不良作用激素受体阳性乳腺癌的预后



在过去的 20 年里,雌激素受体阳性、人表皮生长因子受体 2 (HER2) 阴性转移性乳腺癌患者的治疗方法发生了巨大变化。
更新日期:2024-10-31
down
wechat
bug